Additional processes contribute to the dermatitis caused by the cpd mutation of Sharpin, including TLR3 signaling (24), NLRP3 inflammasome and IL-1β signaling (25, 26), and IL-4 signaling (27). This evidence concerns the gene TLR3 and skin disorder.